Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Prices $3.5M Public Offering

NEW YORK – OpGen said on Monday that it has priced a $3.5 million public offering of 4,495,825 shares of its common stock and accompanying warrants at a combined price of about $.78 per share and warrant. 

The warrants will have the same exercise price per share. They will be exercisable starting on the date of stockholder approval of the issuance of the shares and expire five years later. The offering is expected to close on or about May 4, with H.C. Wainwright as the exclusive placement agent. 

The Rockville, Maryland-based firm plans to use the proceeds to continue US commercialization of its Acuitas AMR Gene Panel test for bacterial isolates and to commercialize its other products, with a focus on the Unyvero platform and tests. The proceeds will also be used for research and development, clinical trials, and regulatory submissions for the company's Unyvero products, as well as for further development and commercialization of subsidiary Ares Genetics' database and service offerings. 

OpGen added that it will also use the funding for directed sales and marketing efforts, to invest in manufacturing and operations infrastructure, and to repay outstanding debts of the company and its subsidiaries. The remaining proceeds will be used for working capital and other general corporate purposes. 

The firm is also amending certain existing warrants to purchase up to 6,396,903 shares of its common stock that were issued between February 2018 and January 2023 with exercise prices ranging from $2.65 to $7.54 per share. The amended warrants will have a reduced exercise price of about $.78 per share, will become exercisable on the date of stockholder approval, and will expire five years later. 

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.